Muscarinic cholinergic receptors in pancreatic acinar carcinoma of rat
✍ Scribed by Gérard Taton; Myriam Delhaye; StéPhane Swillens; Jean Morisset; Louise Larose; Daniel S. Longnecker; Guy G. Poirier
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- French
- Weight
- 486 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The active enantiomer of tritiated quinuclidinyl benzilate (^3^H(‐)QNB) was used as a ligand to evaluate the muscarinic receptors. The ^3^H(‐)QNB binding characteristics of muscarinic cholinergic receptors obtained from normal and neoplastic tissues were studied to determine changes in receptor properties during neoplastic transformation. Saturable and stereospecific binding sites for ^3^H(‐)QNB are present in homogenates of rat pancreatic adenocarcinoma. The proportions of high‐ and low‐affinity agonist binding sites are similar for neoplastic and normal tissues. The density of muscarinic receptors is higher in neoplastic (200 femtomoles/mg protein) than in normal pancreatic homogenates (80 femtomoles/mg protein). The muscarinic binding sites of the neoplastic and fetal pancreas show similar K~D~ values which are higher than those observed for normal pancreas.
📜 SIMILAR VOLUMES
Addition of lithium in vitro inhibited the binding of [3H]( -)QNB to muscarinic cholinergic receptors of homogenates of tissue prepared from the striatum, cortex, and hippocampus of rat brain. Chronic in vivo exposure of rats to lithium in their food produced serum levels of lithium comparable to th
## Abstract The level of binding of a labeled acetylcholine muscarinic antagonist (quinuclidinyl benzilate) to different cerebral membranes has been measured. Of the regions examined, circadian rhythmicity of binding could only be detected significantly in the hippocampus and the hypothalamus and n